Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QAX576 add-on study in persistent uncontrolled asthma
2009-011590-32Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing QAX576 add-on with Placebo add-on (2 arms). Primary endpoint: Asthma Control Questionnaire score. Started Feb 2010; status: completed.
02
Drugs
dectrekumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2009-011590-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011590-32.